or Try an Advanced Search...

    Technical Analysis for ARMP - Armata Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 2.76 -3.50% -0.10
    ARMP closed down 3.5 percent on Wednesday, May 8, 2024, on 38 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical ARMP trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    200 DMA Resistance Bearish -3.50%
    Crossed Above 20 DMA Bullish -3.50%
    Pocket Pivot Bullish Swing Setup -3.50%
    Wide Range Bar Range Expansion -3.50%
    Older End-of-Day Signals for ARMP ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 10 hours ago
    Possible NR7 about 11 hours ago
    Possible Inside Day about 11 hours ago
    Down 3% about 15 hours ago
    Down 2 % about 15 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ARMP Chart by TradingView
    Basic chart:

    Profile

    Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Armata's lead product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. The Company is also developing and advancing a broad pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa, leveraging its proprietary phage-specific GMP manufacturing capabilities.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Antibiotics Bacteria Pseudomonas Staphylococcus Aureus Pathogenic Bacteria Drug Resistance Gram Negative Bacteria Manufacturing Capabilities Pseudomonas Aeruginosa Bacteriophage Multiple Drug Resistance

    Is ARMP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 21 Armata Pharmaceuticals reports Q4 results
    Mar 21 Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update
    Feb 21 Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit
    Nov 14 Armata Pharmaceuticals GAAP EPS of -$0.86, revenue of $1.2M
    Nov 14 Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update
    See more ARMP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.2565
    52 Week Low 1.0701
    Average Volume 16,146
    200-Day Moving Average 3.02
    50-Day Moving Average 3.32
    20-Day Moving Average 2.71
    10-Day Moving Average 2.60
    Average True Range 0.32
    RSI (14) 46.24
    ADX 21.75
    +DI 23.28
    -DI 14.58
    Chandelier Exit (Long, 3 ATRs) 2.89
    Chandelier Exit (Short, 3 ATRs) 3.22
    Upper Bollinger Bands 3.29
    Lower Bollinger Band 2.13
    Percent B (%b) 0.54
    BandWidth 42.79
    MACD Line -0.20
    MACD Signal Line -0.25
    MACD Histogram 0.0462
    Fundamentals Value
    Market Cap 99.76 Million
    Num Shares 36.1 Million
    EPS -1.65
    Price-to-Earnings (P/E) Ratio -1.67
    Price-to-Sales 35.33
    Price-to-Book 4.06
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.87
    Resistance 3 (R3) 2.88 2.85 2.85
    Resistance 2 (R2) 2.85 2.83 2.85 2.84
    Resistance 1 (R1) 2.81 2.81 2.80 2.80 2.84
    Pivot Point 2.78 2.78 2.78 2.78 2.78
    Support 1 (S1) 2.74 2.76 2.73 2.73 2.68
    Support 2 (S2) 2.71 2.74 2.71 2.68
    Support 3 (S3) 2.67 2.71 2.67
    Support 4 (S4) 2.66